Results of a multidisciplinary and intensified treatment program for type 1 Diabetes Mellitus in a Chilean Public Hospital;Resultados de un programa multidisciplinario de tratamiento intensificado de la Diabetes Mellitus tipo 1 (DM1) en un Hospital Público

Revista Medica de Chile

Volumn 131, Issue 8, 2003, Pages 857-864

  Codner D, Ethel ^a,b   Mericq G, Verónica ^a   García B, Hernán ^a   López G, Claudia ^a   Cáceres V, Jeannette ^a   Gaete V, Ximena ^a   Avila A, Alejandra ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Diabetes Mellitus; Health care surveys; Insulin; Insulin dependent

Indexed keywords

CARBOHYDRATE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES CONTROL; EDUCATION PROGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NUTRIENT MANAGEMENT; NUTRITIONAL HEALTH; PSYCHOLOGICAL ASPECT; SCORING SYSTEM; SUPPORT GROUP;

ADOLESCENT; ANTHROPOMETRY; BLOOD GLUCOSE; CHILD; CHILE; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 12444257326     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. NATHAN DM. Long term complications of diabetes mellitus. N Engl J Med 1993; 328: 1070-85.
2. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329; 977-86.
3. UK PROSPECTIVE DIABETES STUDY (UKPDS) GROUP. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
4. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Effect of intensive diabetes treatment on the development and progression of long term complications in adolescents with insulin dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 1994; 125: 177-88.
5. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001; 139: 804-12.
6. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESKARCH GROUP. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000; 342: 381-9.
7. MORTENSEN HB, HOUGAARD P. Comparison of metabolic control in a cross sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes. Diabetes Care 1997; 20: 714-20.
8. RYAN C, VEGA A, DRASH A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 1985; 75: 921-7.
9. BJORGAAS M, GIMSE R, VIK T, SAND T. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr 1997; 86: 148-53.
10. AMERICAN DIABETES ASSOCIATION. Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care 2002; 25: 33S-49.
11. HIRSCH IB. Intensive treatment of type 1 diabetes. Med Clin North Am 1998; 82: 689-719.
12. FRANZ MJ, HORTON ES SR, BANTLE JP, BEEBE CA, BRUNZELL JD, COULSTON AM ET AL. Nutrition principles for the management of diabetes and related complications. Diabetes Care 1994; 17: 490-518.
13. OGDEN CL, KUCZMARSKI RJ, FLEGAL KM, MEI Z, GUO S, WEI R ET AL. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45-60.
14. MARSHALL WA, TANNER JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
15. MARSHALL, WA, TANNER JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23.
16. ROSENBLOOM AL, SCHATZ DA, KRISCHER JP, SKYLER JS, BECKER DJ, LAPORTE RE ET AL. Therapeutic controversy: prevention and treatment of diabetes in children. J Clin Endocrinol Metab 2000; 85: 494-522.
17. GREY M, BOLAND EA, DAVIDSON M, YU C, SULLIVAN-BOLYAI S, TAMBORLANE WV. Short term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care 1998; 21: 902-8.
18. DANNE T, MORTENSEN HB, HOUGAARD P, LYNGGAARD H, AANSTOOT HJ, CHIARELLI F ET AL. Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 2001; 24: 1342-7.
19. ILONEN J, REIJONEN H, KNIP M, SIMELL O. Population based genetic screening for IDDM susceptibility as a source of HLA-genotyped control subjects. Diabetologia 1996; 39: 123.
20. MORÁN A, JACOBS DR JR, STEINBERGER J, HONG CP, PRINEAS R, LUEPKER R ET AL. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999; 48: 2039-44.
21. AMIEL SA, CAPRIO S, SHERWIN RS, PLEWE G, HAYMOND MW, TAMBORLANE WV. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991; 72: 277-82.
22. MURPHY RP, NANDA M, PLOTNICK L, ENGER C, VITALE S, PATZ A. The relationship of puberty to diabetic retinopathy. Arch Ophthalmol 1990; 108: 215-8.
23. HOFFMAN RP, VICINI P, SIVITZ WI, COBELLI C. Pubertal adolescent male-female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model. Pediatr Res 2000; 48: 384-8.
24. DUNGER D, AHMED L, ONG K. Growth and body composition in type 1 diabetes mellitus. Horm Res 2002; 58 Suppl 1: 60-71.
25. CONNORS MH. Growth in the diabetic child. Pediatr Clin North Am 1997; 44: 301-6.
26. JACKSON RL. Growth and maturation of children with insulin dependent diabetes mellitus. Pediatr Clin North Am 1984; 31: 545-67.
27. BROWN DC, STIRLING, HF, BUTLER GE, KELNER CJ, WU FC. Differentiation of normal male prepuberty and hypogonadotrophic hypogonadism using an ultrasensitive luteinizing hormone assay. Horm Res 1996; 46: 83-7.
28. BROWN M, AHMED ML, CLAYTON KL, DUNGER DB. Growth during childhood and final height in type 1 diabetes. Diabet Med 1994; 11: 182-7.
29. DANNE T, KORDONOURI O, ENDERS I, WEBER D. Factors influencing height and weight development in children with diabetes. Results of the Berlin Retinopathy Study. Diabetes Care 1997; 20: 281-5.
30. SEPÚLVEDA A, PÉREZ J, MELLA I. Crecimiento en niños con diabetes mellitus insulino dependientes. Rev Chil Pediatr 1997; 68: 61-5.
31. PURNELL JQ, HOKANSON JE, MARCOVINA SM, STEFFES MW, CLEARY PA, BRUNZELL JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. Jama 1998; 280: 140-6.
32. NATHAN DM. Clinical review 146: The impact of clinical trials on the treatment of diabetes mellitus. J Clin Endocrinol Metab 2002; 87: 1929-37.
33. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995; 75: 894-903.
34. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group. Diabetes Care 1988; 11: 507-73.
35. GREENE AC, TRIPALDI M, CHIARELLI F, MCKIERNAN P, MORRIS A, NEWTON R ET AL. Cross cultural differences in the management of children and adolescents with diabetes. Horm Res 2002; 57 Suppl 1: 75-7.
36. HERMAN WH, EASTMAN RC. The effects of treatment on the direct costs of diabetes. Diabetes Care 1998; 21 Suppl 3: C19-24.
37. KRAMER L, FASCHING P, MADL C, SCHNEIDER B, DAMJANCIC F, WALDHAUSL W ET AL. Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes 1998; 47: 1909-14.
38. WYSOCKI T, HARRIS MA, MAURAS N, FOX L, TAYLOR A, JACKSON SC ET AL. Absence of adverse effects of severe hypoglycemia on cognitive function in school aged children with diabetes over 18 months. Diabetes Care 2003; 26: 1100-5.
39. SHAH SC, MALONE JI, SIMPSON NE. A randomized trial of intensive insulin therapy in newly diagnosed insulin dependent diabetes mellitus. N Engl J Med 1989; 320: 550-4.
40. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Effect of intensive therapy on residual beta cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1998; 128: 517-23.
41. ZINMAN B. Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers. Diabetologia 1997; 40 Suppl 2: S88-90.
42. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Jama 1996; 276: 1409-15.
43. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. Resource utilization and costs of care in the diabetes control and complications trial. Diabetes Care 1995; 18: 1468-78.
44. DAGOGO-JACK S. DCCT results and diabetes care in developing countries. Diabetes Care 1995; 18: 416-7.
45. RATNER RE, HIRSCH IB, NEIFING JL, GARG SK, MECCA TE, WILSON CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. US Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 2000; 23: 639-43.
46. SCHOBER E, SCHOENLE E, VAN DYK J, WERNICKE-PANTEN K. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes. Diabetes Care 2001; 24: 2005-6.
47. MORTENSEN HB. Findings from the Hviclore Study Group on Childhood Diabetes: metabolic control and quality of life. Horm Res 2002; 57 Suppl 1: 117-20.